In the present study, we have identified PIP4K2A as a putative tumor suppressor and demonstrated its inhibitory effects in PI3K’s signaling pathway and clonogenic growth via modulating p85/p110 PI3K complex stability in PTEN-deficient GBMs. The gene discussed is PIP4K2A; the disease is neoplasm.